Evidence map›Paper›PMID 38471129›Full record

Observational studyDeutsches Arzteblatt international2024

Healthcare-Associated Infections and the Use of Antibiotics in German Hospitals—Results of the Point Prevalence Survey of 2022 and Comparison With Earlier Findings.

Seven Johannes Sam Aghdassi, Sonja Hansen, Luis Alberto Peña Diaz, Alexander Gropmann, Selin Saydan, Christine Geffers, Petra Gastmeier, Brar Piening, Michael Behnke

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Deutsches Arzteblatt international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. In Reply.Deutsches Arzteblatt international · 2025
    Article
  10. Point Prevalence Rate Useful Only to a Limited Extent.Deutsches Arzteblatt international · 2025
    Article
  11. Article
  12. An in-depth analysis of antimicrobial prescription quality in 10 non-university hospitals, in southwest Germany, 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Seven Johannes Sam AghdassiCharité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Institute of Hygiene and Environmental Medicine, Berlin, Germany; German National Reference Centre for Surveillance of Nosocomial Infections, Berlin, Germany; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Digital Clinician Scientist Program, Berlin, Germany.
Sonja Hansen
Luis Alberto Peña Diaz
Alexander Gropmann
Selin Saydan
Christine Geffers
Petra Gastmeier
Brar Piening
Michael Behnke
Berlin Institute of Health at Charité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA national point prevalence survey (PPS) of healthcare-associated infections (HAI) and antibiotic use (AU) was carried out in Germany in 2022 in the framework of the European PPS conducted by the European Centre for Disease Prevention and Control (ECDC). The objective was to determine the prevalence of HAI and AU in German hospitals and to compare the obtained values with those of the most recent previous PPS, which was carried out in 2016.

methodsThe German National Reference Center for the Surveillance of Nosocomial Infections was entrusted with the organization of the PPS of 2022. As recommended by the ECDC, each hospital in a representative sample of 50 hospitals was invited to participate, and all other interested hospitals in Germany were also able to participate if desired. The data were collected by specially trained hospital staff in May, June, and July 2022. The definitions and methods put forth by the ECDC were used.

resultsData from 66 586 patients in 252 hospitals were included. The prevalence of HAI in all participating hospitals was 4.9%, and that of AU was 26.9%. The HAI and AU prevalences were essentially unchanged in comparison to 2016. The most common types of HAI were surgical site infection (23.5%), lower respiratory tract infection (21.6%), and urinary tract infection (19.0%).

conclusionHAI were just as frequent in 2022 as in 2016, affecting approximately one in twenty hospitalized patients on any given day.

Indexed as

Anti-Bacterial AgentsCross InfectionAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleGermanyHospitalsHumansMaleMiddle AgedPrevalenceYoung AdultAnti-Bacterial Agents

Identifiers

PMID38471129
PMCPMC11381198
OpenAlexW4394739011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.